Tabiora, Aisa Y.

HRN: 20-07-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2022
CEFUROXIME 500MG (TAB)
10/14/2022
10/21/2022
ORAL
1 Tab
BID
S/P NSVD With Repair Of Laceration
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Multiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: